Cardiovascular disease risk factors in HIV patients – association with antiretroviral therapy. Results from the DAD studyNina Friis‐Møller, Jens Lundgren, Rainer Weber et al.|AIDS|2003Cited by 987
Trends in underlying causes of death in people with HIV from 1999 to 2011 (D:A:D): a multicohort collaborationColette Smith, Jens Lundgren, Lene Ryom et al.|The Lancet|2014Cited by 930
Risk of Myocardial Infarction in Patients with HIV Infection Exposed to Specific Individual Antiretroviral Drugs from the 3 Major Drug Classes: The Data Collection on Adverse Events of Anti‐HIV Drugs (D:A:D) StudySigne Westring Worm, Jens Lundgren, Caroline Sabin et al.|The Journal of Infectious Diseases|2009Cited by 649
Predicting the risk of cardiovascular disease in HIV-infected patients: the Data collection on Adverse Effects of Anti-HIV Drugs StudyNina Friis‐Møller, Rodolphe Thiébaut, Peter Reiss et al.|European Journal of Cardiovascular Prevention & Rehabilitation|2010Cited by 392
Lipid Profiles in HIV‐Infected Patients Receiving Combination Antiretroviral Therapy: Are Different Antiretroviral Drugs Associated with Different Lipid Profiles?Éric Fontas, Frank van Leth, Caroline Sabin et al.|The Journal of Infectious Diseases|2004Cited by 336